OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Investigator: Henrik Zetterberg

4 Projects | 1 Researchers | $6,465,633 Invested

2025

University of Gothenburg

Henrik Zetterberg, MD, PhD

Quality control (QC) program for CSF and plasma biomarkers for Alzheimer’s disease

  • Funding Amount: $1,999,997
  • Organization Type:
  • Program: Diagnostics Accelerator
  • Status: Active

2024

University of Gothenburg

Henrik Zetterberg, MD, PhD

Certified Reference Material and Method for plasma p-tau217

  • Funding Amount: $1,117,740
  • Organization Type: Academic/Nonprofit
  • Program: Diagnostics Accelerator
  • Status: Active

2019

University of Gothenburg

Henrik Zetterberg, MD, PhD

Fully automated plasma assays as screening tests for Alzheimer-related amyloid β pathology

  • Funding Amount: $3,197,896
  • Organization Type: Academic/Nonprofit
  • Program: Diagnostics Accelerator
  • Target: zzAbeta
  • Status: Closed

University of Gothenburg

Henrik Zetterberg, MD, PhD

2024 Annual Goodes Prize for Excellence in Alzheimer's Drug Discovery:

  • Funding Amount: $150,000
  • Organization Type:
  • Status: Closed